Phathom Pharmaceuticals Inc
(NASDAQ:PHAT)
$8.63
1.33[18.22%]
Last update: 5:31PM (Delayed 15-Minutes)
Get Real Time Here
$8.63
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open7.350Close8.430
Vol / Avg.1.027M / 491.903KMkt Cap494.089M
Day Range7.350 - 8.69052 Wk Range5.840 - 17.019

Phathom Pharmaceuticals Stock (NASDAQ:PHAT), Quotes and News Summary

Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.

Open7.350Close8.430
Vol / Avg.1.027M / 491.903KMkt Cap494.089M
Day Range7.350 - 8.69052 Wk Range5.840 - 17.019
Adam Eckert - Oct 30, 2023, 9:16AM
Lisa Levin - Oct 13, 2023, 8:55AM
Vandana Singh - May 24, 2023, 12:31PM
Lisa Levin - Apr 12, 2023, 7:57AM
Lisa Levin - Mar 30, 2023, 12:43PM
Lisa Levin - Feb 15, 2023, 6:57AM
Lisa Levin - Feb 10, 2023, 1:07PM
Vandana Singh - Feb 10, 2023, 1:01PM
Lisa Levin - Feb 10, 2023, 9:47AM
Vandana Singh - Feb 10, 2023, 8:53AM
Globe Newswire - 6 days ago
Globe Newswire - Nov 21, 2023, 5:42PM
Globe Newswire - Nov 11, 2023, 8:18AM
Globe Newswire - Nov 9, 2023, 8:00AM
Globe Newswire - Nov 1, 2023, 5:00PM
Globe Newswire - Oct 30, 2023, 8:00AM
Globe Newswire - Oct 25, 2023, 8:01AM
Globe Newswire - Sep 26, 2023, 8:01AM
Globe Newswire - Sep 21, 2023, 3:17PM
Globe Newswire - Sep 5, 2023, 8:00AM
Full archive of press releases available on Benzinga Pro
InvestorsObserver - 11 hours ago
TipRanks - Nov 10, 2023, 7:01AM
Seeking Alpha - Nov 9, 2023, 5:15PM
TipRanks - Nov 9, 2023, 4:45PM
Seeking Alpha - Nov 9, 2023, 9:07AM
TipRanks - Nov 3, 2023, 6:30AM
TipRanks - Nov 3, 2023, 3:05AM
TipRanks - Nov 2, 2023, 7:56PM
TipRanks - Nov 2, 2023, 12:41PM
InvestorsObserver - Nov 2, 2023, 6:51AM
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-0.890-0.760 0.1300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-11-10NeedhamJoseph StringerReiteratesBuyBuyMaintains-23.00
2023-11-03Goldman SachsPaul ChoiMaintainsNeutralNeutralRaises9.0010.00
2023-09-27NeedhamJoseph StringerReiteratesBuyBuyMaintains-23.00
2023-08-11HC Wainwright & Co.Matthew CaufieldReiteratesBuyBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
PHATPhathom Pharmaceuticals18.22%494.1M
TBPHTheravance Biopharma1.03%535.8M
THRDThird Harmonic Bio2.81%383.4M
GHRSGH Research2.19%340.2M
SNDLSNDL2.67%402.4M
Q

How do I buy Phathom Pharmaceuticals (PHAT) stock?

A

You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Phathom Pharmaceuticals's (PHAT) competitors?

A

Other companies in Phathom Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and WAVE Life Sciences (NASDAQ:WVE).

Q

What is the target price for Phathom Pharmaceuticals (PHAT) stock?

A

The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Needham on Friday, November 10, 2023. The analyst firm set a price target for 23.00 expecting PHAT to rise to within 12 months (a possible 166.51% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Phathom Pharmaceuticals (PHAT)?

A

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $8.63 last updated December 4, 2023 at 10:31 PM UTC.

Q

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

A

There is no dividend information for Phathom Pharmaceuticals.

Q

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

A

Phathom Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 27, 2024.

Q

Is Phathom Pharmaceuticals (PHAT) going to split?

A

There is no upcoming split for Phathom Pharmaceuticals.

Q

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

A

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.